Literature DB >> 24796974

Metabolic monitoring in commercially insured pediatric patients newly initiated to take a second-generation antipsychotic.

Thomas Delate1, Yardlee S Kauffman1, Sheila R Botts2, Charlyn Wong3, Kerri M Gaughan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24796974     DOI： 10.1001/jamapediatrics.2014.224

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN： 2168-6203            Impact factor:   16.193


× No keyword cloud information.
  8 in total

Review 1.  High-risk psychotropic medications for US children with trauma sequelae.

Authors:  E R Barnett; M T Concepcion Zayas
Journal:  Epidemiol Psychiatr Sci       Date:  2018-11-05       Impact factor: 6.892

2.  Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.

Authors:  Rebecca Ronsley; Duc Nguyen; Jana Davidson; Constadina Panagiotopoulos
Journal:  Can J Psychiatry       Date:  2015-10       Impact factor: 4.356

3.  Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.

Authors:  Wenxin Chen; Monica Cepoiu-Martin; Antonia Stang; Diane Duncan; Chris Symonds; Lara Cooke; Tamara Pringsheim
Journal:  Clin Drug Investig       Date:  2018-05       Impact factor: 2.859

4.  Glucose and Prolactin Monitoring in Children and Adolescents Initiating Antipsychotic Therapy.

Authors:  Yasuyuki Okumura; Masahide Usami; Takashi Okada; Takuya Saito; Hideki Negoro; Noa Tsujii; Junichi Fujita; Junzo Iida
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-06-11       Impact factor: 2.576

5.  Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review.

Authors:  Mariken Dinnissen; Andrea Dietrich; Judith H van der Molen; Anne M Verhallen; Ynske Buiteveld; Suzanne Jongejan; Pieter W Troost; Jan K Buitelaar; Barbara J van den Hoofdakker; Pieter J Hoekstra
Journal:  J Clin Psychopharmacol       Date:  2021 Jan/Feb 01       Impact factor: 3.118

6.  Monitoring of Adverse Drug Reaction-Related Parameters in Children and Adolescents Treated With Antipsychotic Drugs in Psychiatric Outpatient Clinics.

Authors:  Lenneke Minjon; Ivona Brozina; Toine C G Egberts; Eibert R Heerdink; Els van den Ban
Journal:  Front Psychiatry       Date:  2021-02-25       Impact factor: 4.157

7.  Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners.

Authors:  Lenneke Minjon; Els van den Ban; Marloes T Bazelier; Arief Lalmohamed; Toine C G Egberts; Eibert R Heerdink
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-10-07       Impact factor: 2.576

8.  Metabolic monitoring in children 5 years of age and younger prescribed second-generation antipsychotic medications.

Authors:  Yardlee S Kauffman; Thomas Delate; Sheila Botts
Journal:  Ment Health Clin       Date:  2018-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.